Latest GlaxoSmithKline Stories
MarketOptimizer.org adds “CountryFocus Healthcare, Regulatory and Reimbursement Landscape – Poland” to its store.
Discover a new revolutionary product that is designed to nourish the brain. Minneapolis, MN (PRWEB) August 18, 2014 In celebration of the 100th anniversary
First Patient Dosed in the EU Post-Authorization Safety Study MOUNTAIN VIEW, Calif., Aug. 14, 2014 /PRNewswire/ -- Alexza Pharmaceuticals, Inc.
New site is filled with information, patient testimonials, easy-to-use tools and real-world tips for people affected by COPD RESEARCH TRIANGLE PARK, N.C., Aug.
LifeScienceIndustryResearch.com adds Latest Report on "Global and Chinese Vardenafil (CAS 224785-90-4) Industry, 2009-2019 Market Research Report" to its store. DALLAS, July 27, 2014
DUBLIN, July 25, 2014 /PRNewswire/ -- Research and Markets has announced the
No. 1 Prescribed Allergy Treatment Ingredient(1) to be Available OTC PARSIPPANY, N.J., July 24, 2014 /PRNewswire/ -- GlaxoSmithKline plc (LSE/NYSE: GSK) today announced that the U.S.
While Expressing Concerns about Reimbursement, EU5 Payers Look Favorably on Identifying Anti-IL5 Therapy-Responsive Patients, According to Findings from Decision Resources Group BURLINGTON,
LONDON, July 23, 2014 /PRNewswire/ -- Global healthcare company GSK reports Q2 results reflecting a business that is facing currency headwinds, increased price competition
- In Roman antiquity, the return of a person who had been banished, or taken prisoner by an enemy, to his old condition and former privileges.
- In international law, that right by virtue of which persons and things taken by an enemy in war are restored to their former status when coming again under the power of the nation to which they belonged.